Elastin-like recombinamers with acquired functionalities for gene-delivery applications

Journal of Biomedical Materials Research - Part A

Volumn 103, Issue 10, 2015, Pages 3166-3178

  Piña, Maria J ^a   Alex, Susan M ^b   Arias, Francisco J ^a   Santos, Mercedes ^a   Rodríguez Cabello, Jose C ^a   Ramesan, Rekha M ^b   Sharma, Chandra P ^b  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

cationic polymers; elastin like recombinamers; ELR; gene therapy; polyplex

Indexed keywords

BIOCOMPATIBILITY; CELL CULTURE; ELASTIN; GENE TRANSFER; GENES; GLYCOPROTEINS; MOLECULAR BIOLOGY; PARTICLE SIZE; POLYMERS;

CATIONIC POLYMERS; ELR; FUNCTIONAL MOTIFS; GLIOMA CELL LINES; NON-VIRAL SYSTEMS; NONVIRAL VECTORS; POLYPLEXES; TRANSFECTION ASSAYS;

GENE THERAPY;

ELASTIN; ELASTIN LIKE RECOMBINAMER; IMIDAZOLE; PENETRATIN; PLASMID DNA; POLYMER; PROTEIN P53; UNCLASSIFIED DRUG; CARRIER PROTEIN; OLIGOPEPTIDE;

AMIDATION; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; CELL VIABILITY; COMPLEX FORMATION; COVALENT BOND; CYTOTOXICITY; ERYTHROCYTE; GENE DELIVERY SYSTEM; GENETIC ENGINEERING; GENETIC TRANSFECTION; GLIOMA CELL LINE; IN VITRO STUDY; INTERNALIZATION; NONHUMAN; PARTICLE SIZE; RAT; RECOMBINANT DNA TECHNOLOGY; SCALE UP; THERMOSTABILITY; ZETA POTENTIAL; ANIMAL; CHEMISTRY; GENE TRANSFER; HUMAN; PLASMID; PROTEIN MOTIF; TUMOR CELL LINE;

AMINO ACID MOTIFS; ANIMALS; CARRIER PROTEINS; CELL LINE, TUMOR; ELASTIN; GENE TRANSFER TECHNIQUES; HUMANS; OLIGOPEPTIDES; PLASMIDS; RATS;

EID: 84937050923     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.35455     Document Type: Article

References (63)

1. Ginn SL, Alexander IE, Edelstein ML, Abedi MR, Wixon J,. Gene therapy clinical trials worldwide to 2012-An update. J Gene Med 2013; 15: 65-77.
2. Manfredsson FP, Bloom DC, Mandel RJ,. Regulated protein expression for in vivo gene therapy for neurological disorders: Progress, strategies, and issues. Neurobiol Dis 2012; 48: 212-221.
3. Alex SM, Rekha MR, Sharma CP,. Spermine grafted galactosylated chitosan for improved nanoparticle mediated gene delivery. Int J Pharm 2011; 410:125-137.
4. Yla-Herttuala S,. Cardiovascular gene therapy with vascular endothelial growth factors. Gene 2013; 525: 217-219.
5. Niven R, Pearlman R, Wedeking T, Mackeigan J, Noker P, Simpson-Herren L, Smith JG,. Biodistribution of radiolabeled lipid-DNA complexes and DNA in mice. J Pharm Sci 1998; 87: 1292-1299.
6. Yin H, Kanasty RL, Eltoukhy AA, Vegas AJ, Dorkin JR, Anderson DG,. Nonviral vectors for gene-based therapy. Nat Rev Genet 2014; 15: 541-555.
7. Hosel M, Broxtermann M, Janicki H, Esser K, Arzberger S, Hartmann P, Gillen S, Kleeff J, Stabenow D, Odenthal M, Knolle P, Hallek M, Protzer U, Büning H,. Toll-like receptor 2-mediated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vectors. Hepatology 2012; 55: 287-297.
8. Mays LE, Vandenberghe LH, Xiao R, Bell P, Nam HJ, Agbandje-McKenna M, Wilson JM,. Adeno-associated virus capsid structure drives CD4-dependent cd8+ T cell response to vector encoded proteins. J Immunol 2009; 182: 6051-6060.
9. Anderson WF,. Human gene therapy. Nature 1998; 392(6679 Suppl): 25-30.
10. Midoux P, Pichon C, Yaouanc JJ, Jaffres PA,. Chemical vectors for gene delivery: A current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers. Br J Pharmacol 2009; 157: 166-178.
11. Mintzer MA, Simanek EE,. Nonviral vectors for gene delivery. Chem Rev 2009; 109: 259-302.
12. Blau S, Jubeh TT, Haupt SM, Rubinstein A,. Drug targeting by surface cationization. Crit Rev Ther Drug Carrier Syst 2000; 17: 425-465.
13. Sahay G, Alakhova DY, Kabanov AV,. Endocytosis of nanomedicines. J Control Release 2010; 145: 182-195.
14. Kosuge M, Takeuchi T, Nakase I, Jones AT, Futaki S,. Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans. Bioconjug Chem 2008; 19: 656-664.
15. Thoren PE, Persson D, Isakson P, Goksor M, Onfelt A, Norden B,. Uptake of analogs of penetratin, tat(48-60) and oligoarginine in live cells. Biochem Biophys Res Commun 2003; 307: 100-107.
16. Lee H, Jeong JH, Park TG,. PEG grafted polylysine with fusogenic peptide for gene delivery: High transfection efficiency with low cytotoxicity. J Control Release 2002; 79: 283-291.
17. Thomas JJ, Rekha MR, Sharma CP,. Unraveling the intracellular efficacy of dextran-histidine polycation as an efficient nonviral gene delivery system. Mol Pharm 2012; 9: 121-134.
18. Rekha MR, Sharma CP,. Hemocompatible pullulan-polyethyleneimine conjugates for liver cell gene delivery: In vitro evaluation of cellular uptake, intracellular trafficking and transfection efficiency. Acta Biomater 2011; 7: 370-379.
19. Hunter AC,. Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity. Adv Drug Deliv Rev 2006; 58: 1523-1531.
20. Grigsby CL, Leong KW,. Balancing protection and release of DNA: Tools to address a bottleneck of nonviral gene delivery. J R Soc Interface 2010; 7(Suppl 1): S67-S82.
21. Al-Dosari MS, Gao X,. Nonviral gene delivery: Principle, limitations, and recent progress. AAPS J 2009; 11: 671-681.
22. Rodriguez-Cabello JC, Martin L, Girotti A, Garcia-Arevalo C, Arias FJ, Alonso M,. Emerging applications of multifunctional elastin-like recombinamers. Nanomedicine 2011; 6: 111-122.
23. Pierna M, Santos M, Arias FJ, Alonso M, Rodriguez-Cabello JC,. Efficient cell and cell-sheet harvesting based on smart surfaces coated with a multifunctional and self-organizing elastin-like recombinamer. Biomacromolecules 2013; 14: 1893-1903.
24. Shi P, Gustafson JA, MacKay JA,. Genetically engineered nanocarriers for drug delivery. Int J Nanomed 2014; 9: 1617-1626.
25. Urry DW., What Sustains Life? Consilient Mechanisms for Protein-Based Machines and Materials. New York: Springer-Verlag; 2006.
26. Sallach RE, Cui W, Balderrama F, Martinez AW, Wen J, Haller CA, Taylor JV, Wright ER, Long RC Jr, Chaikof EL,. Long-term biostability of self-assembling protein polymers in the absence of covalent crosslinking. Biomaterials 2010; 31: 779-791.
27. Arias FJ, Santos M, Fernandez-Colino A, Pinedo G, Girotti A,. Recent contributions of elastin-like recombinamers to biomedicine and nanotechnology. Curr Top Med Chem 2014; 14: 819-836.
28. Walker L, Perkins E, Kratz F, Raucher D,. Cell penetrating peptides fused to a thermally targeted biopolymer drug carrier improve the delivery and antitumor efficacy of an acid-sensitive doxorubicin derivative. Int. J. Pharm. 2012; 436:825-832.
29. Bidwell GL, 3, Raucher D,. Cell penetrating elastin-like polypeptides for therapeutic peptide delivery. Adv Drug Deliv Rev 2010; 62: 1486-1496.
30. Rodriguez-Cabello JC, Girotti A, Ribeiro A, Arias FJ,. Synthesis of genetically engineered protein polymers (recombinamers) as an example of advanced self-assembled smart materials. Methods Mol Biol 2012; 811: 17-38.
31. Girotti A, Reguera J, Arias FJ, Alonso M, Testera AM, Rodríguez-Cabello JC,. Influence of the molecular weight on the inverse temperature transition of a model genetically engineered Elastin-like pH-responsive polymer. Macromolecules 2004; 37: 3396-3400.
32. Angelastro JM, Lame MW,. Overexpression of cd133 promotes drug resistance in c6 glioma cells. Mol Cancer Res 2010; 8: 1105-1115.
33. Naus CC, Elisevich K, Zhu D, Belliveau DJ, Del Maestro RF,. In vivo growth of c6 glioma cells transfected with connexin43 cDNA. Cancer Res 1992; 52: 4208-4213.
34. Li G, Li W, Angelastro JM, Greene LA, Liu DX,. Identification of a novel DNA binding site and a transcriptional target for activating transcription factor 5 in c6 glioma and mcf-7 breast cancer cells. Mol Cancer Res 2009; 7: 933-943.
35. Srinivasachari S, Liu Y, Prevette LE, Reineke TM,. Effects of trehalose click polymer length on pDNA complex stability and delivery efficacy. Biomaterials 2007; 28: 2885-2898.
36. Haupt S, Berger M, Goldberg Z, Haupt Y,. Apoptosis-The p53 network. J Cell Sci 2003; 116: 4077-4085.
37. Bechara C, Sagan S,. Cell-penetrating peptides: 20 years later, where do we stand? FEBS Lett 2013; 587: 1693-1702.
38. Ohmori N, Niidome T, Wada A, Hirayama T, Hatakeyama T, Aoyagi H,. The enhancing effect of anionic alpha-helical peptide on cationic peptide-mediating transfection systems. Biochem Biophys Res Commun 1997; 235: 726-729.
39. Akinc A, Thomas M, Klibanov AM, Langer R,. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med 2005; 7: 657-663.
40. Jokerst JV, Lobovkina T, Zare RN, Gambhir SS,. Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond) 2011; 6: 715-728.
41. Costa RR, Girotti A, Santos M, Arias FJ, Mano JF, Rodriguez-Cabello JC,. Cellular uptake of multilayered capsules produced with natural and genetically engineered biomimetic macromolecules. Acta Biomater 2014; 10: 2653-2662.
42. Bessa PC, Machado R, Nurnberger S, Dopler D, Banerjee A, Cunha AM, Rodríguez-Cabello JC, Redl H, van Griensven M, Reis RL, Casal M,. Thermoresponsive self-assembled elastin-based nanoparticles for delivery of BMPs. J Control Release 2010; 142: 312-318.
43. Sarangthem V, Cho EA, Bae SM, Singh TD, Kim SJ, Kim S, Jeon WB, Lee BH, Park RW,. Construction and application of elastin like polypeptide containing IL-4 receptor targeting peptide. PLoS ONE 2013; 8: e81891
44. Dash BC, Mahor S, Carroll O, Mathew A, Wang W, Woodhouse KA, Pandit A,. Tunable elastin-like polypeptide hollow sphere as a high payload and controlled delivery gene depot. J Control Release 2011; 152: 382-392.
45. Garcia-Arevalo C, Pierna M, Girotti A, Arias FJ, Rodriguez-Cabello JC,. A comparative study of cell behavior on different energetic and bioactive polymeric surfaces made from elastin-like recombinamers. Soft Matter 2012; 8: 3239-3249.
46. Alex SM, Sharma CP,. Enhanced intracellular uptake and endocytic pathway selection mediated by hemocompatible ornithine grafted chitosan polycation for gene delivery. Colloids Surf B Biointerfaces 2014; 122: 792-800.
47. Deng R, Yue Y, Jin F, Chen Y, Kung HF, Lin MC, Wu C,. Revisit the complexation of PEI and DNA-How to make low cytotoxic and highly efficient PEI gene transfection nonviral vectors with a controllable chain length and structure? J Control Release 2009; 140: 40-46.
48. Choi YJ, Kang SJ, Kim YJ, Lim YB, Chung HW,. Comparative studies on the genotoxicity and cytotoxicity of polymeric gene carriers polyethylenimine (PEI) and polyamidoamine (PAMAM) dendrimer in jurkat T-cells. Drug Chem Toxicol 2010; 33: 357-366.
49. Hunter AC,. Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity. Adv Drug Deliv Rev 2006; 58: 1523-1531.
50. Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T,. In vitro cytotoxicity testing of polycations: Influence of polymer structure on cell viability and hemolysis. Biomaterials 2003; 24: 1121-1131.
51. Moghimi SM, Symonds P, Murray JC, Hunter AC, Debska G, Szewczyk A,. A two-stage poly(ethylenimine)-mediated cytotoxicity: Implications for gene transfer/therapy. Mol Ther 2005; 11: 990-995.
52. O'Rorke S, Keeney M, Pandit A,. Nonviral polyplexes: Scaffold mediated delivery for gene therapy. Prog Polym Sci 2010; 35: 441-458.
53. Le Roy C, Wrana JL,. Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat Rev Mol Cell Biol 2005; 6: 112-126.
54. Oupicky D, Konak C, Ulbrich K, Wolfert MA, Seymour LW,. DNA delivery systems based on complexes of DNA with synthetic polycations and their copolymers. J Control Release 2000; 65: 149-171.
55. Zelphati O, Nguyen C, Ferrari M, Felgner J, Tsai Y, Felgner PL,. Stable and monodisperse lipoplex formulations for gene delivery. Gene Ther 1998; 5: 1272-1282.
56. Heitz F, Morris MC, Divita G,. Twenty years of cell-penetrating peptides: From molecular mechanisms to therapeutics. Br J Pharmacol 2009; 157: 195-206.
57. Gupta B, Levchenko TS, Torchilin VP,. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv Drug Deliv Rev 2005; 57: 637-651.
58. Tahara K, Yamamoto H, Kawashima Y,. Cellular uptake mechanisms and intracellular distributions of polysorbate 80-modified poly (D,L-lactide-co-glycolide) nanospheres for gene delivery. Eur J Pharm Biopharm 2010; 75: 218-224.
59. Lachelt U, Kos P, Mickler FM, Herrmann A, Salcher EE, Rödl W, Badgujar N, Bräuchle C, Wagner E,. Fine-tuning of proton sponges by precise diaminoethanes and histidines in pDNA polyplexes. Nanomedicine 2014; 10: 35-44.
60. Chen T-H, Bae Y, Furgeson D,. Intelligent biosynthetic nanobiomaterials (IBNs) for hyperthermic gene delivery. Pharm Res 2008; 25: 683-691.
61. Chen TH, Bae Y, Furgeson DY, Kwon GS,. Biodegradable hybrid recombinant block copolymers for nonviral gene transfection. Int J Pharm 2012; 427: 105-112.
62. Höbel S, Aigner A,. Polyethylenimines for siRNA and miRNA delivery in vivo. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2013; 5: 484-501.
63. Wiseman JW, Goddard CA, McLelland D, Colledge WH,. A comparison of linear and branched polyethylenimine (PEI) with DCChol//DOPE liposomes for gene delivery to epithelial cells in vitro and in vivo. Gene Ther 2003; 10: 1654-1662.